Endocrine Disorders Clinical Trials

Browse 27 Clinical Trials Across 79 Cities

10 Phase 3 Trials · 221 Clinics

Reviewed by Michael Gill, B. Sc.
10 Clinical Trials Near Me
Top Hospitals for Clinical Trials
Image of National Institutes of Health Clinical Center in Maryland.
National Institutes of Health Clinical Center
Bethesda
4Active Trials
0All Time Trials for
1995First Trial
Image of Baylor College of Medicine in Texas.
Baylor College of Medicine
Houston
4Active Trials
0All Time Trials for
2006First Trial
Image of Ascendis Pharma Investigational Site in Wisconsin.
Ascendis Pharma Investigational Site
Madison
3Active Trials
0All Time Trials for
2020First Trial
Image of Ascendis Pharma Investigational Site in Texas.
Ascendis Pharma Investigational Site
Houston
3Active Trials
0All Time Trials for
2020First Trial
Image of Seattle Children's Hospital in Washington.
Seattle Children's Hospital
Seattle
3Active Trials
0All Time Trials for
2009First Trial
Top Cities for Clinical Trials
Image of Seattle in Washington.
Seattle
11Active Trials
Seattle Children's HospitalTop Active Site
Image of Bethesda in Maryland.
Bethesda
9Active Trials
National Institutes of Health Clinical CenterTop Active Site
Most Recent NullTop Treatments for Clinical Trials
Treatment Name
Active Clinical Trials
All Time Trials for
First Recorded Trial
Crinecerfont
2
2
2020
BMN 111
2
2
2016
Chronocort
2
2
2021
Lonapegsomatropin
2
2
2020
Sequential Dose
1
1
2023

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 11th, 2021

Last Reviewed: August 6th, 2023

References1 Savarirayan R, Irving M, Bacino CA, Bostwick B, Charrow J, Cormier-Daire V, Le Quan Sang KH, Dickson P, Harmatz P, Phillips J, Owen N, Cherukuri A, Jayaram K, Jeha GS, Larimore K, Chan ML, Huntsman Labed A, Day J, Hoover-Fong J. C-Type Natriuretic Peptide Analogue Therapy in Children with Achondroplasia. N Engl J Med. 2019 Jul 4;381(1):25-35. doi: 10.1056/NEJMoa1813446. Epub 2019 Jun 18. https://pubmed.ncbi.nlm.nih.gov/312695462 Berg C, Meinel T, Lahner H, Yuece A, Mann K, Petersenn S. Diagnostic utility of the glucagon stimulation test in comparison to the insulin tolerance test in patients following pituitary surgery. Eur J Endocrinol. 2010 Mar;162(3):477-82. doi: 10.1530/EJE-09-0824. Epub 2009 Dec 8. https://pubmed.ncbi.nlm.nih.gov/199961993 Savarirayan R, De Bergua JM, Arundel P, McDevitt H, Cormier-Daire V, Saraff V, Skae M, Delgado B, Leiva-Gea A, Santos-Simarro F, Salles JP, Nicolino M, Rossi M, Kannu P, Bober MB, Phillips J 3rd, Saal H, Harmatz P, Burren C, Gotway G, Cho T, Muslimova E, Weng R, Rogoff D, Hoover-Fong J, Irving M. Infigratinib in children with achondroplasia: the PROPEL and PROPEL 2 studies. Ther Adv Musculoskelet Dis. 2022 Mar 21;14:1759720X221084848. doi: 10.1177/1759720X221084848. eCollection 2022. https://pubmed.ncbi.nlm.nih.gov/353424574 Auchus RJ, Buschur EO, Chang AY, Hammer GD, Ramm C, Madrigal D, Wang G, Gonzalez M, Xu XS, Smit JW, Jiao J, Yu MK. Abiraterone acetate to lower androgens in women with classic 21-hydroxylase deficiency. J Clin Endocrinol Metab. 2014 Aug;99(8):2763-70. doi: 10.1210/jc.2014-1258. Epub 2014 Apr 29. https://pubmed.ncbi.nlm.nih.gov/247800505 Yuen KC, Biller BM, Molitch ME, Cook DM. Clinical review: Is lack of recombinant growth hormone (GH)-releasing hormone in the United States a setback or time to consider glucagon testing for adult GH deficiency? J Clin Endocrinol Metab. 2009 Aug;94(8):2702-7. doi: 10.1210/jc.2009-0299. Epub 2009 Jun 9. https://pubmed.ncbi.nlm.nih.gov/195091046 Gómez JM, Espadero RM, Escobar-Jiménez F, Hawkins F, Picó A, Herrera-Pombo JL, Vilardell E, Durán A, Mesa J, Faure E, Sanmartí A. Growth hormone release after glucagon as a reliable test of growth hormone assessment in adults. Clin Endocrinol (Oxf). 2002 Mar;56(3):329-34. https://pubmed.ncbi.nlm.nih.gov/119400447 Yuen KC, Frystyk J, Rhoads SA, Bidlingmaier M. Pegvisomant-primed glucagon stimulation test in assessing GH reserve and GH/IGF kinetics in adults suspected of GH deficiency. Pituitary. 2016 Feb;19(1):65-74. https://pubmed.ncbi.nlm.nih.gov/264967678 New MI, Gertner JM, Speiser PW, del Balzo P. Growth and final height in classical and nonclassical 21-hydroxylase deficiency. Acta Paediatr Jpn. 1988;30 Suppl:79-88. https://pubmed.ncbi.nlm.nih.gov/31468829 Yuen KC, Biller BM, Molitch ME, Cook DM. Clinical review: Is lack of recombinant growth hormone (GH)-releasing hormone in the United States a setback or time to consider glucagon testing for adult GH deficiency? J Clin Endocrinol Metab. 2009 Aug;94(8):2702-7. doi: 10.1210/jc.2009-0299. Epub 2009 Jun 9. Review. https://pubmed.ncbi.nlm.nih.gov/1950910410 Yuen KC, Frystyk J, Rhoads SA, Bidlingmaier M. Pegvisomant-primed glucagon stimulation test in assessing GH reserve and GH/IGF kinetics in adults suspected of GH deficiency. Pituitary. 2016 Feb;19(1):65-74. doi: 10.1007/s11102-015-0688-8. https://pubmed.ncbi.nlm.nih.gov/26496767